A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Advanced or Metastatic Solid Tumors
- Breast Cancer
- Non -Small Cell Lung Cancer
- Ovarian Cancer
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04875806
- Collaborators
- Not Provided
- Investigators
- Study Director: Han Myint, MD NextCure, Inc.